Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name A-1331852
Trade Name
Drug Descriptions

A-1331852 inhibits BCL-XL, resulting in increased tumor cell apoptosis and decreased tumor growth (PMID: 25787766, PMID: 32145345).

DrugClasses BCL-XL inhibitor 14
CAS Registry Number 1430844-80-6


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
A-1210477 + A-1331852 A-1210477 A-1331852 0 0
A-1331852 A-1331852 0 0
A-1331852 + Buparlisib A-1331852 Buparlisib 0 0
A-1331852 + Docetaxel A-1331852 Docetaxel 0 0
A-1331852 + Ipatasertib A-1331852 Ipatasertib 0 0
A-1331852 + MIK665 A-1331852 MIK665 0 0
A-1331852 + S63845 A-1331852 S63845 0 0

Additional content available in CKB BOOST